American Journal of Ophthalmology
Volume 139, Issue 6 , Pages 972-982, June 2005

Intravitreal Versus Retrobulbar Injections of Triamcinolone for Macular Edema Associated With Branch Retinal Vein Occlusion

  • Ken Hayashi, MD

      Affiliations

    • Hayashi Eye Hospital, Fukuoka, Japan.
    • Corresponding Author InformationInquiries to Ken Hayashi, MD, Hayashi Eye Hospital, 4-7-13 Hakataekimae, Hakata-ku, Fukuoka 812-0011, Japan; fax: 81-92-441-5303
  • ,
  • Hideyuki Hayashi, MD

      Affiliations

    • Department of Ophthalmology, School of Medicine, Fukuoka University, Fukuoka, Japan.

Accepted 28 December 2004. published online 03 May 2005.

Purpose

To compare the short-term effect of intravitreal versus retrobulbar injection of triamcinolone acetonide for the treatment of macular edema caused by branch retinal vein occlusion.

Design

Randomized clinical trial.

Methods

Sixty eyes of 60 patients who had macular edema associated with branch retinal vein occlusion were randomly assigned to receive a single intravitreal injection (4 mg) or repeated retrobulbar injections (40 mg, three times) of triamcinolone. These injections (first injection in the retrobulbar group) were given approximately 1 week after focal laser photocoagulation. Using optical coherence tomography, the central retinal (foveal) thickness and total macular volume were measured before and at 1 and 3 months after injection. Visual acuity, intraocular pressure, and the incidence of reinjection were also examined. Fifty-two patients (86.7%) completed the 3-month follow-up.

Results

The mean foveal thickness and total macular volume decreased significantly after either intravitreal or repeated retrobulbar triamcinolone injections. Foveal thickness and macular volume were significantly less after intravitreal injection than after repeated retrobulbar injections, although there had been no significant differences at baseline. The percent reductions in foveal thickness and macular volume were also greater after intravitreal injection than after retrobulbar injections. Improvement in visual acuity was significantly better after intravitreal injection than after the retrobulbar injections. The incidence of intraocular pressure rise (to ≥20 mm Hg) was greater in the intravitreal group than in the retrobulbar group, but this was readily controlled by the use of antiglaucoma medications. After completion of the 3-month follow-up, 24 patients (46.2%) underwent reinjection. The need for reinjections was significantly greater in the retrobulbar group than in the intravitreal group (P = .0001).

Conclusions

A single intravitreal injection of triamcinolone is significantly more effective than are repeated retrobulbar injections in reducing macular edema associated with branch retinal vein occlusion, and leads to greater improvement in visual acuity.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(04)01630-7

doi:10.1016/j.ajo.2004.12.087

American Journal of Ophthalmology
Volume 139, Issue 6 , Pages 972-982, June 2005